Typewriter Therapeutics
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $56M
Investors
- 5
About Typewriter Therapeutics
Founded in 2025 and based in Massachusetts, US, Typewriter Therapeutics, Inc. operates as a biotechnology company that provides RNA-based genetic medicines and gene insertion platforms for cancer, autoimmune, and rare genetic diseases.
Who invested in Typewriter Therapeutics
5 investors across 1 round
See all investors in Typewriter Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 2, 2026
Amount
$56M
Investors
Questions about Typewriter Therapeutics
Who invested in Typewriter Therapeutics?
Typewriter Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Typewriter Therapeutics raised?
Typewriter Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Typewriter Therapeutics last raise money?
Typewriter Therapeutics's most recent round on record is a Series A, in Sep 2026.
What does Typewriter Therapeutics do?
Founded in 2025 and based in Massachusetts, US, Typewriter Therapeutics, Inc.
Where is Typewriter Therapeutics headquartered?
Typewriter Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Typewriter Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Typewriter Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Typewriter Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.